IL-33 as a Novel Serum Prognostic Marker of Intracerebral Hemorrhage

Table 1

Baseline characteristics according to 3-month prognosis in patients with ICH.

Characteristics on admission	3-month prognosis		values
	Good ()	Poor ()
Age (years)			0.284
Gender, male/female	91/57	165/89	0.485
Hypertension (, %)	118	200	0.814
DM (, %)	37	49	0.178
Hyperlipidemia (, %)	75	122	0.609
CHD (, %)	14	29	0.540
SBP (mmHg)			0.283
DBP (mmHg)			0.770
TG (mmol/L)			0.300
LDL-C (mmol/L)			0.072
HbA1c (mmol/L)			0.131
FBG (mmol/L)			0.407
APTT			0.650
INR			0.456
NHISS scores			0.039
GCS scores			<0.001
Hematoma volume (mL)			0.025
Serum IL-33 (pg/mL)			<0.001

ICH: intracranial hemorrhage; DM: diabetes mellitus; CHD: coronary heart disease; SBP: systolic pressure; DBP: systolic pressure; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HbA1c: glycated hemoglobin; FBG: fasting blood glucose; APTT: activated partial thromboplastin time; INR: international normalized ratio; NHISS: National Institutes of Health Stroke Scale; GCS: Glasgow Coma Scale; IL-33: interleukin 33.